Statistical modeling of Agatston score in multi-ethnic study of atherosclerosis (MESA)

Shuangge Ma1, Anna Liu, Jeffrey Carr

  • 1School of Public Health, Yale University, New Haven, Connecticut, United States of America. Shuangge.ma@yale.edu

Plos One
|August 17, 2010
PubMed

Insights

Statistical models for coronary artery calcium (CAC) in the Multi-Ethnic Study of Atherosclerosis (MESA) were investigated. Semiparametric models best describe CAC development, while parametric models suffice for prediction.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Biostatistics
  • Medical Imaging Analysis

Background:

  • The Multi-Ethnic Study of Atherosclerosis (MESA) cohort provides data on subclinical cardiovascular disease.
  • Coronary artery calcium (CAC) is a key risk factor for coronary heart disease, with a zero-inflated distribution in MESA.
  • Existing statistical models for zero-inflated data have limitations, including reliance on parametric assumptions and limited focus on estimation and prediction properties.

Purpose of the Study:

  • To investigate advanced statistical modeling techniques for analyzing coronary artery calcium (CAC) data from the MESA study.
  • To compare the estimation and prediction properties of various two-part statistical models, including parametric and semiparametric, proportional and nonproportional variants.
  • To determine the most appropriate statistical approach for fully describing the relationship between covariates and CAC development versus predicting CAC.

Main Methods:

  • Utilized two-part statistical models to analyze the zero-inflated distribution of coronary artery calcium (CAC) scores in the MESA cohort.
  • Investigated both parametric and semiparametric modeling approaches.
  • Examined both proportional and nonproportional covariate effect models to assess their estimation and prediction capabilities.

Main Results:

  • Semiparametric models with nonproportional covariate effects are necessary for a comprehensive description of the relationship between covariates and CAC development.
  • Parametric models with proportional covariate effects are adequate and sufficient for the prediction of CAC.
  • The study highlights distinct modeling requirements for understanding CAC etiology versus predicting future risk.

Conclusions:

  • The choice of statistical model is crucial and depends on the research objective: understanding mechanisms versus prediction.
  • Semiparametric models offer deeper insights into the biological mechanisms driving CAC development.
  • Parametric models provide a practical and efficient tool for predicting CAC scores in clinical and research settings.

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...